-
Experts Offer CGM Tips for Type 1 Diabetes
12 Mar 2024 07:38 GMT
… Advanced Technologies & Treatments for Diabetes meeting, two leading CGM … , MD, professor of medicine at the University of California … program developed to translate trial data and clinical … the fast-acting inhaled insulin Afrezza and reducing — although …
-
INHALE-3 Study’s Initial Meal Challenge Results Comparing Afrezza® Head-To-Head With Multiple Daily Injections (MDI) and Insulin Pumps
11 Mar 2024 10:05 GMT
… 4 U.S. clinical trial evaluating inhaled insulin (plus basal) vs. standard … Dr. Hirsch, Professor of Medicine and Diabetes Treatment and Teaching Chair at the … at: ClinicalTrials.gov(NCT05904743). About Afrezza
Afrezza (insulin human) Inhalation Powder is a …
-
3 Biotech Stocks Investors Are Watching for Future Growth
02 Feb 2024 15:03 GMT
… medicine and the growing portfolio of orphan drug … the surging demand for biotechnology tools in agricultural … company provides Afrezza, an inhaled insulin to treat diabetes, and … development for the potential treatment of nontuberculous mycobacterial ( …
-
MannKind Announces Completion of Enrollment in U.S. Phase 4 Inhale-3 Clinical Trial in Patients Living With Type 1 Diabetes
06 Nov 2023 11:15 GMT
… injectable insulin or pumps to inhaled insulin (Afrezza® (insulin human) … trial evaluating inhaled insulin (combined with basal insulin) … Clinical Development and Medical Affairs for MannKind … of diseases such as diabetes, pulmonary arterial hypertension …
-
Non-injectable Insulin Market Size to Exceed USD 2.23 Billion by 2030, with a CAGR of 8.6%, according to Persistence Market Research
23 Jan 2024 12:38 GMT
… options include oral medications, inhalable forms … Afrezza, having shown promising results in clinical trials … Pharmaceuticals
Adocia
Oramed Pharmaceuticals
Dance Biopharm
Medtronic
Non-injectable Insulin … centers for diabetes treatment, influencing patient …
-
Non-Injectable Insulin Sales to Surge at 9.50% CAGR by 2034, Fueled by R&D and Innovation | Future Market Insights, Inc
23 Nov 2023 13:30 GMT
… like Afrezza, inhaled insulin … diabetes have benefited from technology.
With modern insulin treatment solutions, managing insulin … Pills, Sprays, Others), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Drug … Medical Devices, and Pharmaceutical …
-
Clincal trial in Sacramento focuses on development of inhaled insulin for children
23 Nov 2023 04:43 GMT
… Macedo said. The clinical trial is studying its safety … version of insulin to children.
This medication is already … 2 diabetes.
The inhaled version of insulin is called Afrezza and … sites statewide holding the clinical trials called "Inhale." …
-
Sacramento clinical trial could bring inhalable insulin to children
14 Nov 2023 01:15 GMT
CALIFORNIA, USA — Afrezza is an inhalable form of insulin that's changed … . So, Afrezza it mostly eliminates that," Haaland said.
This trial is … type 1 or type 2 diabetes. You can sign your child … hope is to finish the trial by December 2024.
-
Wear The Gown: Inhaled insulin clinical trial looking for young participants
28 Sep 2023 00:07 GMT
… , "Patients with type one diabetes, their pancreas gradually does not … insulin. They have insulin resistance."
The study being conducted by the Diabetes … overall trial. It compares the safety of both Afrezza, which is inhaled insulin …
-
7 Pharma Stocks to Buy for Groundbreaking Treatments and Robust Revenue Growth
07 Sep 2023 13:15 GMT
… trials. At any point, a drug could fail a trial, … include Afrezza, an inhaled insulin treatment for people with diabetes that’ … plans to buy Reata Pharmaceuticals (NASDAQ:RETA), which … making everything from medicines and vaccines to animal health products …